Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 2, 2006, Pages 150-154

  Tsai, Moan Shane ^a   Kuo, Ching Yuan ^a   Wang, Ming Chung ^a   Wu, Hong Cheng ^a   Chien, Chun Chih ^a   Liu, Jien Wei ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Aeromonas; Bacteremia; Hematologic neoplasms; Microbial sensitivity tests; Risk factors

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AEROMONAS; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; DEMOGRAPHY; FEMALE; GRAM NEGATIVE SEPSIS; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; RISK ASSESSMENT; TAIWAN; TERTIARY HEALTH CARE;

AEROMONAS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BACTEREMIA; CONSCIOUSNESS DISORDERS; DRUG RESISTANCE, BACTERIAL; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HOSPITALS; HUMANS; IMIPENEM; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PIPERACILLIN; PROGNOSIS; RISK FACTORS; SHOCK, SEPTIC; TAIWAN; TIME FACTORS;

EID: 33745477448     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abbott SL. Aeromonas. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology, 8th ed., Washington DC: American Society for Microbiology; 2003:701-5.
2. Janda JM, Abbott SL. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998; 27:332-44.
3. Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis 1995;20:1298-304.
4. Clark NM, Chenoweth CE. Aeromonas infection of the hepatobiliary system: report of 15 cases and review of the literature. Clin Infect Dis 2003;37:506-13.
5. Lau SM, Peng MY, Chang FY. Outcomes of Aeromonas bacteremia in patients with different types of underlying disease. J Microbiol Immunol Infect 2000;33:241-7.
6. Funada H, Matsuda T. Aeromonas bacteremia in patients with hematologic diseases. Intern Med 1997;36:171-4.
7. Carnahan AM, Behram S, Joseph SW. Aerokey II: a flexible key for identifying clinical Aeromonas species. J Clin Microbiol 1991;29:2843-9.
8. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard, 5th ed. NCCLS document M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.
9. Abbott SL, Cheung WK, Janda JM. The genus Aeromonas: biochemical characteristics, atypical reactions, and phenotypic identification schemes. J Clin Microbiol 2003;41:2348-57.
10. Janda JM, Guthertz LS, Kokka RP, Shimada T. Aeromonas species in septicemia: laboratory characteristics and clinical observations. Clin Infect Dis 1994;19:77-83.
11. Sherlock CH, Burdge DR, Smith JA. Does Aeromonas hydrophila preferentially colonize the bowels of patients with hematologic malignancies? Diagn Microbiol Infect Dis 1987;7:63-8.
12. DePauw BE, Verweij PE. Infections in patients with hematologic malignancies. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3432-41.
13. Yuan SS, Lin LP. Isolation and characterization of Aeromonas from seafoods in Taipei. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1993;26:78-85.
14. Vila J, Marco F, Soler L, Chacon M, Figueras MJ. In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sobria. J Antimicrob Chemother 2002;49:701-2.
15. Rossolini GM, Walsh T, Amicosante G. The Aeromonas metallo-beta- lactamases: genetics, enzymology, and contribution to drug resistance. Microb Drug Resist 1996;2:245-52.
16. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.